Buprenorphine Case Presentations: An Illustration of Best Practices
Presented by: Aaron Newcomb, D.O., Shawnee Health Care Carbondale, ABPM – Addiction Medicine Subspecialty, IAFP Board Member

Wednesday, January 24 from 7:00 - 8:00 pm CT

Free for IAFP Members; $50 for Non-Members

Learning Objectives:

- Understand Buprenorphine treatment length is best measured in years rather than months and that open-ended treatment is the standard of care.
- Identify that Benzodiazepines are not a contraindication for buprenorphine treatment.
- Recall that Buprenorphine treatment alone is effective with or without counseling.
- Explain that restricting the dose of buprenorphine does not align with evidence-based medicine.
- Discover that continued drug use is NOT an indication for tapering or discontinuing buprenorphine.

Click here to register